Week 5 Flashcards
Mechanism of Action of anti-cholinergics
- Block cholinergic receptors –> smooth muscle relaxation –> bronchodilation
- Block cholinergic receptors –> decreased mucus production
- Recall: acetylcholine = parasympathetic = bronchoconstriction
Mechanism of Action of Beta-agonists
Bind B2 receptors –> smooth muscle relaxation –> bronchodilation
SABAs
albuterol terbutraline
LABAs
salmeterol formoterol
Why use corticosteroids with B-agonists?
Long-term use of B-agonists causes downregulation of B-receptors. Corticosteroids cause up-regulation of B-receptors, so when you have an acute attack, corticosteroids make your SABA more effective.
Side Effects of B-2 agonists
- Muscle tremor (skeletal muscle β2 receptors) particularly in elderly
- Tachycardia (Atrial β2 receptors, myocardial β1 receptors at high doses)
- Hypokalemia (K+ flux into skeletal muscle) Potentially serious in certain situations but rarely observed with inhaled forms
- Ventilation perfusion mismatch (shunting of blood to poorly ventilated areas) usually not a problem although significant drop in paO2 can occur in COPD
anti-cholinergic drugs
- ipatropium
- tiotropium
Inhaled corticosteroid drugs
- Beclomethasone
- Fluticasone
Systemoic corticosteroid drugs
- Prednisone
- Hydrocortisone
Treatment of choice for asthma
Inhaled B-2 agonists
Benefit of inhaled vs. oral B-2 agonists
- Inhaled minimizes systemic exposure –> minimizes side effects
Anti-cholinergic therapeutic considerations for asthma
- Often used in patients who don’t respond well to B2 agonists
- older patients who have a tremor from B2 agonists
- Less effective than B2 agonists
Anti-cholinergic therapeutic considerations for COPD
- These can be more effective than B2 agonists for COPD treatment
Corticosteroids mechanism of action
- Regulate transcription factors = broad effects
- Delayed response due to changes in transcription factors
What class of drug is used to induce pulmonary surfactant production?
- Corticosteroids
Effects of corticosteroids
- Suppress inflammatory response
- Suppress mucus secretions
- Increase B2 receptors on cell surface, which makes B2 agonists more effective when used in conjunction
- Overall they don’t directly impact smooth muscle contraction but they do impact hyperresponsiveness
Inhaled corticosteroid drugs
- Beclomethasone
- Fluticasone
Systemic corticosteroid drugs
- Prednisone
- Hydrocortisone
When are inhaled corticosteroids used?
- In all forms of asthma now
- Recently new guidelines say that inhaled corticosteroids should be used in conjunction with SABA even for mild asthma
Inhaled corticosteroids used for COPD or CF?
- Not really
- Resistance to corticosteroids is pretty common for both COPD and CF
When are systemic corticosteroids used?
- Acute exacerbations of asthma
Side effects of inhaled corticosteroids
- dysphonia (problems w/ your voice)
- oral candidiasis (i.e. flush)
- cough
side effects of systemic corticosteroids
- much worse than inhaled corticosteroids
- Most significant: adrenal suppression and insufficiency
- Due to exogenous corticosteroids
- SLOW TAPER is critical for these patients
Anti-IgE receptor drug
- Omalizumab
- Used for asthma
- Prevents IgE from binding to mast cell –> prevents degranulation and release of inflammatory cytokines
Anti-IL-5 antibody drugs
- Mepolizumab
- Reslizumab
Delivery of omalizumab
SubQ injection every 2-4 weeks
Main side effect of biologics
- Immune response to the monoclonal Antibody itself
Indication for anti IL-5 antibody drugs
- Eosinophilic asthma
Leukotriene Receptor antagonist drugs
- Montelukast
- Zafirlukast
5-lipoxygenase inhibitor drug(s)
- Zileuton
Mechanism of action of leukotriene modifier drugs
- Leukotriene is an inflammatory molecule released during an immune response
- The leukotriene receptor antagonists block binding of leukotriene
- The 5-lipoxygenase inhibitor blocks the enzyme (lipoxygenase) that actually synthesizes leukotriene
Therapeutic uses of leukotriene modifiers
- Particularly effective in aspirin-induced asthma
- Not effective for COPD
Side effects of leukotriene modifiers
- RARE: liver toxicity
- Generally safe and well tolerated
Bronchiectasis definition
- pathologic enlargement of the airways
- Result: fill with sputum and secretions
Bronchiectasis vs. bronchitis
- Both see chronic coughing and sputum production
- Bronchiectasis has PURULENT (infected) sputum
- Bronchiectasis recurs while bronchitis resolves with treatment
CXR of bronchiectasis
- Fibrosis –> thickenings on Xray
CT-scan of bronchiectasis
- Diagnostic test
- See sacs of air = enlarged airways
Traction bronchiectasis
- Pulmonary fibrosis –> scarring –> airways stay opened
Pathogenesis of bronchiectasis
- Most common cause: infection
- TB can cause it
- Childhood injury to airway and resulting abnormal growth can cause it
Result of bronchiectasis
- Impaired secretion clearance
- Chronic infection
Pathogenesis of CF
- Autosomal recessive
- CFTR mutation –> dysfunctional CFTR protein
- CFTR protein = channel protein for chloride
- Dysfunctional protein –> low chloride –> low water –> thickened mucus –> cilia cannot clear mucus –> infections
Most common bacterial infections in CF patients
- Staph
- Pseudomonas
Clinical Progression of CF
- Normal lungs at birth
- slow recovery from respiratory infections
- Chronic infection –> bronchiectasis (chronic inflammation + enlarged airways filled w/ mucus)
- Deterioration of pulmonary function tests
- Obstructive disease
- Episodes of exacerbations
- Eventual respiratory failure
Most common mutation in CF
- F508del
- Causes misfolded protein that does not get trafficked to cell surface
Diagnosis of CF
- Sweat test
- High chloride and sodium in sweat b/c dysfunctional protein means chloride cannot get out but it also cannot get reabsorbed
- Genotyping
G551D mutation
- Another common mutation in CF
- protein is made and gets to the cell membrane, but the ion channel doesn’t work b/c the gate won’t open
Medications used to treat CF
- DNAse
- DNA makes up majority of the thick mucus secretions
- DNAse chews up the secretions to make it easier to clear
- Nebulized saline
- Pulls fluid into the airway –> loosens mucus secretions
- Inhaled antibiotics
- Especially to treat exacerbations
- Ivacaftor
- Designed to treat G551D mutation, which is only about 5% of patients
- Elexacaftor/Texacaftor/Ivacaftor
- Targets F508del and G551D mutations
- Approved October 2019
Mechanical treatments for CF
- Percussion
- Vests
- Blow into device that causes vibrations
Ultimate cure for CF
- Lung transplants
Pathophysiology of a small Pulmonary Embolism
- Increased dead space
- Normally this would increase pCO2, but the patient compensates
- Compensatory response is to increase respiratory rate, so what you end up seeing is a low pCO2 and respiratory alkalosis.
- You still see low pO2 due to hypoxemia
Cause of hypoxemia in small PE
- V/Q mismatch
- Ventilation but no perfusion
- Blood flow is diverted to other areas of the lung
- Ventilation but no perfusion
- Reduced cardiac output
- You’ll see a reduced MVO2 b/c lower CO –> more oxygen extraction at the level of the tissues
Pathophysiology of large PE
- LARGE PE can result in build up of lactic acidosis due to oxygen starvation in tissues
- You’ll see a metabolic acidosis in this case
- Large emboli –> Increased PVR (due to toxic mediators + hypoxemia causes vasoconstriction) –> right ventricular failure –> inadequate left ventricular filling –> decreased cardiac output –> hypotension and shock.
Infarct physiology of PE
- Pulmonary Infarct may occur w/ PE
- See these things potentially
Common Findings with PE
- Respiratory alkalosis – due to V/Q mismatch and increased respiratory rate to compensate
- Respiratory acidosis – due to LARGE PE à hypotension and shock
- Calf pain/swelling – most statistically significant
Risk Factors for PE
- Virchow’s Triad
- Stagnant blood
- Abnormal coagulation
- Tissue injury
- Recent travel
Most important sign for PE
- Calf swelling/tenderness
Common symptoms for PE
- Dyspnea
- Pleuritic chest pain
- Hemoptysis
- Leg swelling/pain
Common Signs for PE
- Tachypnea
- Low grade fever
- Friction Rub
- Increased P2
- Rales
- Wheezes
- Calf swelling/tenderness
First test when you suspect PE
- Doppler ultrasound
- if you see a clot, then you assume the lung issues are PE
Wells score
- Used to categorize people’s risk for PE
- A score above a 4 is high risk
D-dimer test
- Used when you suspect PE
- If positive, you do a CT angiography
V/Q scan and utility
- Used when suspected PE
- Inject radiolabeled albumin
- The albumin will get caught where the clot is and you’ll be able to visualize where blood flow is and is not
- High clinical suspicion + abnormal V/Q = VERY high likelihood of PE
- Low clinical suspicion + normal V/Q = VERY high likelihood it is NOT a PE
- Anything in the middle = the test is not very useful/predictive
Treatment of PE
- Hemodynamically unstable: heparin + thrombolytic + coumadin
- Hemodynamically stable: heparin + coumadin
Most common thrombolytics for PE
- tPA (tissue plasminogen activator)
- urokinase
- Streptokinase (less commonly)
What do we do for PE patients who cannot tolerate a clot buster?
- Insert filter into inferior vena cava to catch clots
- Problem: this is associated with increased risk of lower extremity thrombosis
What do we do re: long-term treatment for PE?
- Treat with warfarin for 3 – 6 months IF THEY HAVE A DEFINED REVERSIBLE RISK FACTOR.
- If you cannot find their risk factor, it’s recommended they stay on life-long anticoagulation
Define asthma
- Airway inflammation
- Bronchial hyperresponsiveness
- Obstructive lung disease
Pathophysiology of asthma
- Environmental trigger –> inflammatory response
- Two responses to this inflammatory response that narrow the airways:
- Bronchospasm of smooth muscle around bronchioles
- Increased mucus secretion
Pathologic changes in the airways in asthma
- More goblet cells in epithelial lining –> increased mucus secretions
- Sub-basement membrane is thickened
- More immune cells present
- In REALLY bad cases of asthma, you’ll see mucus plugs, REALLY thick layer of smooth muscle
Primary asthma symptoms
- Coughing
- Wheezing
- Shortness of breath
- Tightness in the chest
Diagnosis of asthma
- Episodic symptoms are present
- Airflow obstruction is present
- Exclude alternative diagnoses
- COPD
- vocal cord dysfunction
- allergic bronchopulmonary aspergillosis
Tests to diagnose asthma
- Physical exam
- Wheezing in lung sounds
- Decreased breath sounds is a REALLY bad sign b/c they have progressed beyond just wheezing and now they’re not moving any air basically at all
- Spirometry
- See scooped expiratory curve on Volume-Flow loop
- Decreased FVC and FEV1
- Methacholine Testing
- Good test to rule OUT asthma
- If pre-test probability for asthma is really high, a negative methacholine doesn’t help that much
- If pre-test probability for asthma is quite low, a negative test makes it really unlikely that the person has asthma
- Checks to see whether patient has hyperresponsiveness
- Method: Have them inhale methacholine to induce bronchospasm. If the FEV1 drops 20%, it indicates hyperresponsiveness. (Most people will have a small reaction to methacholine but not this much.)
- Good test to rule OUT asthma
How to assess severity of asthma?
- Frequency of exacerbation
- Night-time symptoms?
- Severity of symptoms
- Impairing daily function?
- Frequency of medication use
- Frequency of hospital visits
- Spirometric readings – how bad is FEV1/FVC and Peak Expiratory Flow Rate
- Severe asthma will show Decreased FEV1, or PEF <40%
- Life Threating asthma can show same markers at <25%
Basic pharmacologic approach to treating asthma
- Mild may just need a short-acting bronchodilator (albuterol)
- Next steps: inhaled corticosteroids, long acting bronchodilators, biologics, oral corticosteroids
pharmacologic properties of main asthma medications
- Albuterol = beta-agonist = bronchodilator
- Corticosteroids = TF activation that is widespread = anti-inflammatory
- Biologics = bind to immune antibodies like IgE that causes release of all sorts of inflammatory cytokines
Factors that can worsen asthma
house dust mite allergy
tobacco smoke
cats
seasonal allergens
Markers of acute asthma
- Difficulty speaking in full sentences
- Quiet chest (when they have progressed beyond wheezing). This is a BAD sign.
- paCO2 > 45 mmHg
- Oxygen Sat < 90%
- FEV1 or PEF < 40%
- Life-threatning asthma can show these parameters at less than 25%
- Confusion/coma
Definition of COPD
- A common, preventable, and treatable disease characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities, usually caused by significant exposure to noxious particles or gases
Prevalence of COPD
- 20% of COPD is NOT smoking related
- Highest prevalence in rural areas
How to diagnose COPD
- Symptoms
- Risk factors
- Spirometry
COPD symptoms
dyspnea
chronic cough
sputum
spirometry in COPD
FEV1/FVC < 70%
COPD risk factors
- SMOKING
- Indoor cooking w/ coal or wood
- childhood respiratory infections
- alpha-1-antitrypsin deficiency
Two forms of COPD
- chronic bronchitis
- emphysema
Pathophysiology of chronic bronchitis
- Problem with the airway
- Chronic inflammation –> mucus hypersecretion –> airway obstruction
- See increased number of goblet cells
clinical diagnosis for chronic bronchitis
- chronic productive cough for 3 months in each of 2 successive years
Pathophysiology of emphysema
- Toxin (i.e. cigarette smoke) –> neutrophil degranulation –> release of elastase (protease that breaks down elastin)
- Cigarette smoke also decreases alpha-1-antitrypsin, a protective antiprotease
- Together results in destructino of elastin –> permanent enlargement of air spaces = floppy balloon
- Results in hyperinflation, air trapping, imparired gas exchange
spirometry readings in COPD
- Decreased FEV1/FVC
- Increased TLC (due to air trapping)